Oxford-AstraZenecaBritain made a new decision regarding the vaccine while the debates about it continued. Pharmaceuticals and Healthcare Products Regulatory Authority (MHRAIn the statement, it was stated that the Oxford-AstraZeneca vaccine still has great benefits in preventing serious diseases. In the statement, which was announced that 79 blood clotting cases were reported until 31 March and 19 of these people died, it was emphasized that it was not determined what caused the blood clotting. It was…"‘Oxford-AstraZeneca’ will not be made for under 30s in England"
The fast and determined attitude of the UK in vaccination causes both the number of cases and casualties to decrease day by day. In England, where approximately 32 million people received one dose and five million people received two doses, the number of deaths caused by the virus was recorded as 10 last day. Speaking about the number of cases and loss of life, which has declined to the lowest level since the beginning of…"Loss of life in England fell to 10, big drop in cases over 70 years old"
Researchers from the University of Glasgow examined health data from 192,239 British and Scottish adults from 2003 to 2017. In the same period, it was determined that deaths due to smoking decreased from 23.1 percent to 19.4 percent, and deaths due to obesity and excess body fat increased from 17.9 percent to 23.1 percent. “Smoking has been the main target of public health interventions for many years, as smoking is the leading cause of avoidable…"Death rate due to obesity exceeds deaths due to smoking in England"